Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • India leading the SDG dialogue with 56 countries and 4100 participants at the RISE World Summit 2022 Press Release
  • Remotify CEO Maria Sucgang Earns Nomination for Tatler Front & Female Awards Philippines 2026 Business
  • Independent music artists bet big on Music NFTs from FanTiger Business
  • Celebrating Women’s Day: Sharadhi Ravindra’s Story of Determination and Achievement Business
  • Aftab Dawa: Inspiring Student Empowerment via Blogging and YouTube Education
  • Financepeer transforming the education ecosystem of Pune through fee financing Business
  • Kolkata Hiring Rises 4%: Recruitment Mantra’s Arghya Sarkar on How Businesses Can Find the Right Talent Business
  • Dynamic Cables Successfully Participates in Nepal Electric Power Lights, ELECRAMA and MEE Expo Business

Concept Medical Receives Third US FDA’s IDE Approval for Its Magictouch – Sirolimus Coated Balloon in Small Vessel Indication

Posted on May 1, 2023 By

Surat (Gujarat) [India], May 1: Concept Medical Inc. (CMI), a global leader in drug delivery devices, has received its third Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its novel Sirolimus-coated balloon, Magic Touch SCB, for the treatment of Small Vessels (SV) in coronary arteries. This milestone comes after CMI received IDE approvals for Magic Touch SCB to treat Coronary In-Stent Restenosis (ISR) in September 2022 and Magic Touch PTA to treat “Below the Knee” Peripheral Arterial Diseases (PAD) in February 2022.

Small vessel disease affects up to 30% of patients undergoing PCI, and revascularization of small vessels is challenging due to increased technical failure rates and an elevated risk of restenosis with PCI, which can result in repeated interventions. Small Vessel Disease is also a predictor of Major Adverse Cardiac Events (MACE). The IDE approval allows Concept Medical to conduct pivotal clinical studies to gather safety and effectiveness data for the Magic Touch Sirolimus Coated Balloon in small vessel coronary disease. This data will support a future pre-market approval (PMA) application in the USA, providing patients and physicians with an alternate product for the treatment of CAD.

The CE approved Magic Touch SCB is the world’s first Sirolimus-coated Balloon with extensive commercial usage in Europe, major markets of Asia, and the Middle Eastern markets, with over 100,000 patients treated with Magic Touch SCB in these markets. CMI has the distinction of developing the world’s first Sirolimus Coated Balloon and Drug-eluting stent, with over 114 granted patents for its drug delivery platforms. The company has even completed Clinical Trials in Japan, with an expected PMDA approval in Japan soon. These USFDA IDE approvals provide CMI with access to the US market.

Currently, there are no FDA approved Drug Coated Balloons for the treatment of CAD in the USA, and the patients are limited to the availability of Drug Eluting Stents and uncoated Balloons. MagicTouch has already been widely studied globally in multiple clinical trials, most notably the EASTBOURNE Registry (2123 patients), NANOLUTE, and ongoing trials like the TRANSFORM 1, TRANSFORM 2, GINGER, TITAN, and Hybrid Bifurcation DEB. Sirolimus has already proven to be safer in coronary artery disease treatment.

Notably, no Indian company has received IDE approval for a Drug-Coated Balloon in the USA, either in the Peripheral or Coronary indications. CMI’s innovation and success in obtaining three IDE approvals in different treatment indications highlight India’s research capabilities in the medical field. This achievement has the potential to be a game changer for the healthcare industry, healthcare professionals, and patients at large, providing with an alternate product for the treatment CAD & PAD.

Dr. Martin Leon, Founder of the Cardiovascular Research Foundation, will lead the coming IDE trials and stresses the importance of this achievement, stating, “The FDA-approval to initiate the MAGICAL -SV Clinical trial using the Magic Touch sirolimus-covered balloon with nanolute technology represents a landmark event in our decades-long quest to find an optimal therapy to manage patients with small vessel coronary obstructive disease.”

Dr Manish Doshi, founder and managing director of Concept Medical, expressed his appreciation for the approvals, stating, “We are deeply honored to receive three IDE approvals from the US FDA for our Sirolimus drug-coated balloons for the treatment of coronary and peripheral arterial diseases. This brings us closer to offering innovative treatment options to patients in the US and represents a significant leap in the field of Vascular Space for our flagship product, ‘Magic Touch,’ which is the world’s first Sirolimus Coated Balloon with roots in INDIA making the country proud.”

About MagicTouch SCB:

MagicTouch SCB is a CE marked and commercially marketed Sirolimus-coated balloon developed by Concept Medical, using proprietary Nanoluté Technology. MagicTouch SCB has been used in >50,000 patients in major global markets.

About Concept Medical Inc (CMI):

CMI is headquartered in Tampa, Florida, and has operational offices in The Netherlands, Singapore, and Brazil, with manufacturing units in India. CMI specializes in developing drug-delivery systems and has unique and patented technology platforms that can be deployed to deliver any drug/pharmaceutical agent across the luminal surfaces of blood vessels.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Health Tags:Healthcare

Post navigation

Previous Post: “India Compressor and Vacuum Industry Thrives with INDIA COMVAC SHOW 2023”
Next Post: Vcare’s Treatment For Hair Loss And Hair Thinning

Related Posts

  • Exceptional Skin Rejuvenation Results through Radio Frequency Microneedling, vouches Dr. Anju Methil, Skin and Shape Clinic Health
  • Dr. Balaraju Naidu Revolutionizes Orthopedics with Robotic Surgeries; ONUS Hospital Celebrates 5th Anniversary Health
  • International Gut Health Expert Brings 25 Plus years of expertise to the community life at nature Health
  • Dr. Bhasker Sharma: Pioneering Homeopath and All India Secretary of the Medical Wing Health
  • From Practitioner at someone’s else Dentistry to owning a Dentistry- Story of Maverick Entrepreneur Dr. Parham Shafe Health
  • Zenzo Leads the Way with 5G-Enabled Ambulances for Seamless Healthcare Delivery in Mumbai Health

Recent Posts

  • The 110th Anniversary Celebration of Baptist Church Karol Bagh Trust
  • The Quiet Rewiring of the Customer Conversation
  • Suntech Infra Solutions Limited Announces H1 FY27 Results
  • Share Samadhan Limited Delivers Robust Consolidated H1 FY27Performance; EBITDA Surges Over 21-Fold, PAT Rises 854.65% and Revenue Grows 157.24%
  • Consistent’s AAGO Unveils 98-Inch Interactive Display for Next-Generation Classrooms and Boardrooms

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • IFSCA spotlights India investment opportunities in Investor Awareness Series Business
  • Life Health Foods Launches So Good OAT Beverage In India In The Plant-Based Dairy-Free Segment Business
  • Dr Niket Patel of Akanksha IVF hospital and research institution awarded best IVF hospital by former Gujarat Deputy CM Nitin Patel Business
  • QubeHealth changes the way India pays for healthcare Business
  • Economists, Historians and Legal Experts Call for Deeper National Conversation on India’s British Colonial Legacy Lifestyle
  • Daas Labs unveils ScikIQ to accelerate the digital transformation journey for enterprises Business
  • The Vanishing Shelf — How Streaming Platforms Learned To Delete Without Making Noise Entertainment
  • California entrepreneur launches new energy startup Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme